Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 43598-505

5 FDA label images from Dr.reddy�s Laboratories Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 43598-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy�s Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label – Raloxifene, 60mg Bottle, 30ct (60 mg 1000tab)

Package Label – Raloxifene, 60mg Bottle, 30ct (60 mg 1000tab)
Label for Raloxifene Hydrochloride Tablets, USP 60 mg, film-coated oral tablets. The label indicates a package size of 1,000 tablets and is distributed by Dr. Reddy's Laboratories Inc. It includes a barcode, directions to dispense the Medication Guide, and storage instructions. The label also shows the product NDC 43598-505-10 and a note stating 'No Varnish.'*
FDA Label Image

Package Label – Raloxifene, 60mg Bottle, 30ct (60 mg 100tab)

Package Label – Raloxifene, 60mg Bottle, 30ct (60 mg 100tab)
Raloxifene Hydrochloride Tablets, USP 60 mg film-coated tablets, packaged 100 count, labeled by Dr. Reddy's Laboratories Inc. The label includes dispensing instructions, storage conditions, and a barcode with the product NDC 43598-505-01. It is marked as Rx Only for oral use and states the absence of varnish.*
FDA Label Image

Package Label – Raloxifene, 60mg Bottle, 30ct (60 mg 30tab)

Package Label – Raloxifene, 60mg Bottle, 30ct (60 mg 30tab)
Label for Raloxifene Hydrochloride Tablets, USP 60 mg, film-coated oral tablets. The label indicates a quantity of 30 tablets per container and is labeled by Dr. Reddy's Laboratories Inc. The label includes dispensing instructions for pharmacists and a barcode with the NDC 43598-505-30.*
FDA Label Image

Figure 1 (Raloxifene Pi 02v1)

Figure 1 (Raloxifene Pi 02v1)
Two line graphs depicting total hip mean percentage change from baseline over 24 months after randomization. The first graph compares raloxifene and placebo groups in studies from North America and the European Union, showing percentage change over time. The second graph compares placebo, raloxifene, and conjugated estrogens (CE) in hysterectomized women, showing their respective percentage changes over 24 months. Both include intent-to-treat analyses with last observation carried forward.*
FDA Label Image

Raloxifene Pi

Raloxifene Pi
Chemical structure of raloxifene hydrochloride showing its molecular framework, including aromatic rings, hydroxyl groups, and a hydrochloride ion (Cl-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.